BioPonroy Harpagophytum
Food supplement declared in France, declaration No 2019-3-744
BioPonroy Harpagophytum (Yves Ponroy) is a food supplement declared in France. Status: retrait du marché annoncé pour le 28 March 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Yves Ponroy
- Food business operator placing the product on the market
- HAVEA COMMERCIAL SERVICES
- Status
- Retrait du marché annoncé pour le 28 March 2027
- Form
- Gélule
- Daily dose
- 2 gélules
- Directions for use
- à avaler
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Calculs rénaux, Ulcère (estomac ou duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
Declaration 163183, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 28 March 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Extrait sec hydroalcoolique | 400 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Fibres solubles d'acacia | not declared |
Additives
E553b
Other ingredients
Gélule végétale
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Yves Ponroy